According to Alnylam Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $2.00 B. In 2023 the company made a revenue of $1.82 B an increase over the years 2022 revenue that were of $1.03 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.